FindTrial
Sign In

Assessment of post operative pain after Total Lparoscopic Hysterectomy

Assessment of Vaginal Vault infiltration by Bupivacaine for postoperative pain after Total Laparoscopic Hysterectomy : ARandomized Control Trial .

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/024994
Enrollment
60
Registered
2020-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle

Interventions

Intervention1: ofInfiltration of 0.25% 10ml of Bupivacaine in the vaginal vault: Intervention Group A in which Bupivacaine will be inflitrated laparoscopically after suturing the vault. Control I

Sponsors

Department of Obstetrics and Gynaecology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients who needs TLH with or without bilateral salpingo-oophorectomy for benign conditions. 2. Uterine size

Exclusion criteria

Exclusion criteria: 1. Presence of malignancy 2. Contraindication to any medication which will be used in the study (Bupivacaine, paracetamol) 3. History of chronic PID 4. History of previous multiple surgeries

Design outcomes

Primary

MeasureTime frame
Comparison of post operative pain and short term morbidity in both the groups.Timepoint: on post operative day 0. 3hours, 6hours, 8 hours 12 and 24 hours—

Secondary

MeasureTime frame
NONETimepoint: NONE—

Countries

India

Contacts

Public ContactKANIKARAM POOJITHA KALYANI

ALL INDIA INSTITUTE OF MEDICAL SCIENCES

drkkroy2003@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026